Back

Utility of a polygenic risk score for incident CHD: interplay with lifestyle in a multi-ethnic cohort of more than 60,000 individuals

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: scores (2) Scores ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Carlos Iribarren

Kaiser Permanente of Northern California, Oakland (United States of America)

7 More presentations in this session

Presentation thumbnail
AF in TAVR patients: double trouble means double care
Doctor C. Oliveira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Validation of the PRECISE-DAPT score in a population-based sample of patients undergoing percutaneous coronary intervention with stent implantation
Mr C. Lim (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Improving risk stratification of recurrent myocardial infarction in a large real-world dataset using machine learning
Professor Z. Vered (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Clinician-reported EHRA and NYHA scores only moderately reflect patient-reported quality of life in atrial fibrillation and heart failure
Doctor J. Van De Pol (Eindhoven, NL)
Abstract Slides Video
Presentation thumbnail
ASGARD risk scores for long-term, individualized cardiovascular surveillance of low-risk patients with asymptomatic non-severe aortic valve stenosis: development and internal validation
Doctor E. Hadziselimovic (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk assessment: scores (2)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
Cardiovascular prevention in older adults
thumbnail
Congress Presentation
Making personalised prevention everyone's business

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources